Heart Failure

Viewing Page 1 of 1 | Showing Results 1 - 10 of 10

HVP Hemodynamic-GUIDEd Management of Heart Failure (Guide HF)

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population...

Jacob Abraham MD
  • Providence St. Vincent Medical Center

Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)

Inclusion Criteria:-New York Heart Association (NYHA) Class II or III-A diagnosis of chronic ischemic left ventricular dysfunction secondary to...

Paul Huang, M.D.
  • Swedish Medical Center

HVP Apogee addendum in Destination Therapy (DT) Post Approval Study (PAS) patients.

Patients must be enrolled in DT PAS first: The purpose of the Apogee study is to further enhance scientific understanding of the implant procedure,...

Jacob Abraham MD
  • Providence St. Vincent Medical Center

A Study to Evaluate the Corvia Medical, Inc. IASD® System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure

Following supine bicycle exercise testing to assess eligibility, the eligible patients are randomized to the treatment or control group.All...

John Mignone, M.D.
  • Swedish Medical Center

HVP Destination Therapy Post Approval Study (DT PAS)

Key Inclusion Criteria:1. Patient or legally authorized representative provides written authorization and/or consent per institution and...

Jacob Abraham MD
  • Providence St. Vincent Medical Center

GUIDE-HF Hemodynamic-GUIDEd Management of Heart Failure

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population...

Heidi Nicewarner
  • Providence Regional Medical Center Everett

PREEMPT-HF Precision Event Monitoring of Patients with Heart Failure using HeartLogic

The goal of PREEMPT-HF study is to collect device and clinical event data to evaluate extended applications of HeartLogic. Heart Failure Diagnostic...

Vivek Bhatia, M.D.
  • Providence Regional Medical Center Everett

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population including heart failure (HF) patients outside of the present indication, but at risk for future HF events or mortality.

Inclusion Criteria:1. Diagnosis and treatment for heart failure (HF) (regardless of left ventricular ejection fraction (LVEF)) for 90 days prior to...

John Mignone, M.D.
  • Swedish Medical Center

DFC AMG 20110203 GALACTIC-HF-A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

Key Inclusion Criteria:•Male or female, ≥ 18 to ≤ 85 years•History of chronic HF (defined as requiring treatment for HF for a minimum of 30 days...

Daniel Eisenberg, M.D.
  • PMI Cardiology - DO NOT USE
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

Injectafer® A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM),...

Vivek Bhatia, M.D.
  • Everett Clinic
  • Providence Medical Group Everett
Viewing Page 1 of 1 | Showing Results 1 - 10 of 10